Ebix, Inc.
Q2 2022 Earnings Call Transcript
Published:
- Operator:
- Ladies and gentlemen, thank you for standing by, and welcome to the Ebix, Inc. Second Quarter 2022 Investor Call. At this time all participants are in a listen-only mode. After the speakersโ presentation, there will be a question-and-answer session. [Operator Instructions] I would like to turn the call over to your host, Darren Joseph. You may begin.
- Darren Joseph:
- Thank you. Welcome everyone to Ebix Inc. 2022 second quarter earnings conference call. Joining me to discuss the quarter is Ebix's Chairman, President and CEO, Robin Raina; Ebix's Global CFO, Steve Hamil; and Ebix's North American President, Ash Sawhney. Following our remarks, we'll open up the call for your questions. Now, let me quickly cover the safe harbor. Some of the statements that we make today are forward-looking, including among others, statements regarding Ebix's future investments, our long-term growth and innovation, the expected performance of our businesses, and our use of cash. These statements involve a number of risks and uncertainties that might cause actual results to differ materially from those projected in the forward-looking statement. Please note that these forward-looking statements reflect our opinions only as of the date of this presentation and we undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements in light of new information or future events. Additional information concerning factors that could cause actual results to materially differ from those in the forward-looking statements made today is contained in our SEC filings which list a more detailed description of the risk factors that may affect our results. Our press release announcing the second quarter 2021 results was issued this morning. The audio of this investor call is also being webcast live on the web at www.ebix.com/webcast. You can look at Ebix's financials beyond what has been provided in this release on our website www.ebix.com. The audio and the text transcript of this call will be available also on the investor homepage of the Ebix website after 4
- Steve Hamil:
- Thanks, Darren. Ebix has seen the positive impact of the return to normalcy within its COVID-19 impacted businesses. While we still have work to do to achieve pre-COVID-19 operating levels in businesses such as travel, foreign exchange, remittance and e-learning, during Q2 2022, the Company saw the largest improvement in these businesses in several quarters with material growth in travel, which increased 399% year-over-year and 157% sequentially. Foreign exchange was up 199% year-over-year and 38% sequentially. Our remittance business increased 16% year-over-year and 47% sequentially. And our e-learning business grew 596% year-over-year and 102% sequentially. Impressive growth numbers. Our worldwide revenues excluding prepaid gift cards increased 32% year-over-year in the same quarter of 2022. Total GAAP revenues increased by 2% year-over-year, which was driven by growth in the above mentioned businesses as well as year-over-year growth in Latin America, Canada and the U.S. LifeSpeed and Annuity Exchange business. This growth was offset in part by a 14% year-over-year decline in our low-margin prepaid gift card revenues during the second quarter. On a constant currency basis, global revenues increased 6% during the quarter. Our Latin American business was heavily impacted by COVID-19 but for the second consecutive quarter, Latin American revenues have shown material growth, increasing 62% year-over-year in Q2 2022, which follows Q1 2022 year-over-year growth of 27%. Ebix signed an amended pricing agreement with our largest customer in Latin America, which has materially increased pricing currently and prospectively. In the U.S., our LifeSpeed and Annuity Exchange business on a combined basis increased 21% year-over-year as industry transaction levels increased and we continue to grow revenues from our existing client base. Additionally, our CRM solution generated year-over-year revenue growth for the second consecutive quarter, increasing 3%. Our European business, whose technology powers the front end of the London and reinsurance and insurance markets continues to perform steadily. While Q2 2022 GAAP revenues decreased 4% year-over-year, on a constant currency basis, those revenues increased 7% year-over-year. In Australia, foreign currency movements had a meaningful negative impact on our results. In Q2 2022, Australian revenues decreased 9% year-over-year, but on a constant currency basis, revenues were down 1% to 2%. Q2 2021 revenues in Australia were the highest revenues for a second quarter since COVID-19 emerged globally since Australia had a tough comp this quarter from a revenue standpoint. Ebix had year-over-year increase in G&A expenses of $8.4 million in Q2 2022, driven by increased personnel costs, including travel expenses of approximately $4.7 million and an increase in bad debt expense of approximately $2.8 million year-over-year, due primarily to a 2021 reduction of the allowance for doubtful accounts associated with our Ebix's volume joint venture and an increase in bad debt expense related to the Ebix's cash travel business during the second quarter of 2022. During the year-to-date period of 2022, we have the following major cash uses, $19 million of cash interest paid, $24 million for income-related taxes paid globally, a combined $14 million expended on CapEx and software development costs, $16 million used to reduce the principal outstanding on our corporate credit facility, $1.47 million -- $1.7 million used to reduce the balances of our working capital facilities in India, and $4.6 million for dividend payments. We funded these initiatives from existing cash plus operating cash flows generated during the year. As of June 30, 2022, the Company has liquidity on hand which includes cash, cash equivalents, short-term investments and restricted cash of $96.7 million versus $125.2 million at 12/30/21. For the year-to-date 2022 period versus the similar period in 2021, Ebix paid an incremental $12 million in cash taxes and $5 million in cash interest, while also investing an incremental $8 million in the Company in the form of capital expenditures and software development costs. Interest costs will remain higher for the balance of 2022 based on the current rate environment and our current borrowing spread being 100 basis points higher than in 2021. Cash taxes for the remainder of 2022 should not be as high as the first half of 2022. While CapEx and software development costs will likely not materially different from the second half of 2021, where we expended approximately $8.2 million to invest in PP&E and our software solutions. Our total debt at June 30, 2022 was $641 million, a reduction of $33 million from total debt of $674 million as of June 30, 2021. Ebix has seen some material improvements in COVID-19 impacted businesses currently and we are optimistic that in the coming quarters we will reach pre-COVID-19 operating levels in these negatively impacted businesses. Globally, we continue to believe that the diversity of our revenues and the market positions that we have provide our shareholders with compelling value creation long-term. We believe that our company has the people, solutions, services and global reach to thrive over the long run. I want to thank the thousands of employees around the world for all their hard work and allow Ebix to provide strong customer experiences globally. Finally, our Form 10-Q will be filed later today. I would like to now turn the call over to the President of our North American insurance businesses, Ash Sawhney for his remarks on the second quarter 2022 operations.
- Ash Sawhney:
- Thank you Darren and Steve, I will now talk about the North American results and outlook. The North American revenue in Q2 of 2022 was up approximately 1% compared to Q2 of 2021. The highlight for the quarter was a strong performance of our core exchanges comprised of life and annuity, health, P&C, illustration, CRM and risk compliance, which were collectively up 5% compared to the same quarter last year. Our life and annuity business exchanges comprised of order entry platforms, illustration exchange, and CRM were up 10% in Q2 of 2022, compared to the same quarter last year. The strong results from our core business were partially offset with declines in our noncore consulting businesses, as well as medical certification and health content business. Compared to Q1, the North American revenue was down 1% sequentially in Q2. This was primarily due to the previously reported one time revenue deferral in the medical certification business, which was taken in Q1. Barring that one time deferral, the business would have been up 1% sequentially. I will now provide a more granular overview of each of the underlying businesses. The annuity exchange revenues were up approximately 25% compared to the same quarter last year, and 15% sequentially compared to Q1 of 2022. The annuity division now is the largest business unit in the U.S. in terms of revenue, as compared to all other U.S. based exchanges. Transactional volumes were up approximately 32% in Q2 2022, compared to the same quarter last year, as well as sequentially compared to Q1. The growth is attributed to a steady increase in both, carrier and distributors on the platform, which now surpasses 55 carriers and over 100 distributors. We added static core [ph] to the annuity exchange in Q2. Other notable accomplishments include products from Nationwide, MassMutual and Banner Life successfully going live on our exchange platforms. The growth is also significantly aided by industry tailwinds as a result of higher interest rates compared to 2021. The illustration exchange was up 1% in Q2 of 2022, compared to the same quarter last year, and up 1.5% sequentially. Over the past several quarters, we have seen a steady increase in transactional volume on the platform. Also benefiting the platform are initiatives we launched last year, which include analytics and integration with third-party presales tools such as Ensight. The CRM revenue was up 3% in Q2 of 2022, compared to the same quarter last year, but down 10% compared to Q1. Revenues in Q1 are typically higher as we see an uptick in revenue from data feeds. We are continuing to expand the sales team and are instituting programs to expand our relationship with broker dealers. The P&C exchange was up 13% in Q2 compared to the same quarter last year. We added several clients including a large municipality in Oklahoma, a large supermarket chain in Minneapolis and a large TPA in Florida. The Ebix Health Exchange was up 6% in Q2 of 2022, compared to the same quarter last year, and relatively flat sequentially. Notable accomplishments in the quarter include an expansion of relationship with Cisco and AIG, as well as successful implementation of Redirect Health, Blue Water and Georgia Dental Association. We are also actively engaged in implementing Aon, which was a new deal announced previously. The underwriting exchange revenue, though down 2.3% in Q2 compared to the same quarter last year, was up 3.5% sequentially. All clients remain steady, additional products and features were delivered at Ameritas, CUNA Mutual and Indiana Farm Bureau. The medical certification business in Q2 2022 was flat relative to the same quarter last year and was down 7% sequentially compared to the previous quarter. The decline was due to the 1 time deferred revenue in Q1. The digital business stayed strong, growing 10% year-to-year compared to last year. We signed 12 new course contracts including Mount Sinai, Howard Hospital, and USCF. We are also building a new customer segmentation platform, which will allow us to better target new customers and will help in customer retention. In the Health Education A.D.A.M. business, we added 12 new clients, including Amway and John Hopkins University. The risk compliance business was up 2% in Q2 compared to the same quarter last year and 5% sequentially. We added eight new clients this quarter, including Luke [ph] Family Farms, Fetzer Vineyards, and Chicago Atlantic. Overall, we are pleased that we are back on a growth path this year, as compared to previous years, when we saw COVID-19-related declines in our business. There are several factors we believe that will contribute to ongoing momentum. Core exchanges will continue to show healthy gain. We are continuing to add new carriers and distributors on our platform at a good pace. Each new participant on the platform contributes to a growing base of recurring revenue. The outlook for a high interest rate environment will continue to be beneficial for several of our businesses. Recent additions in our sales team has had a positive contributing effect. We are pleased with the talent and caliber of people we are able to attract to the organization. With each new sales member bringing their own network to the table, the pipeline is stronger than it has been in recent times. The steps we have taken to integrate our sales, product and delivery organizations has positioned us to pursue larger digital transformational deals. Our average deal size is continuing to grow, as we are able to offer packaged solutions. We are continuing to roll out new modules, such as Edison, the DTCC plug-in, and analytics for life and annuities. We will be launching a series of EBIX indices that will provide market trends and visibility and will generate opportunities for deeper engagements with clients and on custom studies. Our strategy to more closely align our consulting group with the product groups will generate positive results. We are now pre-packaging our consulting services with our new product sales. This provides faster product launches for our clients and gives us incremental revenue opportunities. We are starting to see a slight improvement in the hiring conditions and also the attrition rates in the industry are starting to improve. These factors will help our businesses that rely heavily on professional services support such as our underwriting exchange. We are also expanding offices into second tier cities in India to increase capacity. The recent decision to open an office in a few state capitals with a lower cost base but abundant resources availability is expected to provide relief later this year. While we are pleased with the positive momentum in organic growth, we also anticipate supplementing this with strategic acquisitions, once the India IPO gives us the flexibility. We expect there to be a shakeout in the market. Several companies that had mushroomed during the past boom years with business models that were showing heavy losses in exchange of promises of future growth will likely not survive. Ebix will be in a good position to acquire some of these businesses at distressed valuations. The sound Ebix business model focused on profitable growth and its strength due to diversity of its businesses are reasons why Ebix will emerge even stronger when the dust settles. Finally, we are planning a big Ebix exposition in Q1 of 2023. This event will be attended by top carriers and distributors from the industry. It will allow us to showcase the latest in innovation and our future roadmaps of various exchanges. More on this to follow. I would like to close by thanking team Ebix. I'm truly proud of their work and accomplishments that they have put us on this progressive path and position of strength. I will now pass this along to Robin for his comments.
- Robin Raina:
- Good morning, everyone. I want to start by congratulating our team for an outstanding quarter with great all round performance. What stood out for me in the quarter was, one, the 32% growth in worldwide revenues excluding the prepaid card business, the 6% constant currency revenue growth year-over-year, the year-over-year EbixCash revenue growth of 56% excluding the prepaid cards business, year-over-year growth in 9 of the 10 geographies on a constant currency basis, all three business channels, namely insurance exchanges EbixCash and risk compliance solutions channel showing year-over-year growth on a GAAP and constant currency basis, risk compliance solutions channel showing revenue growth of 21% year-over-year, EBITDA plus stock-based compensation of $36 million in Q2 2022, constant currency revenues of $260.1 million implying annual revenue run rate north of $1 billion. This performance has a special meaning when you consider the time we live in nowadays. The recent inflation downturn, the steep continued increase in employee costs, the strengthening U.S. dollar, and of course, a resource crunch associated with what's going on in the Indian technology labor market. Let me now discuss the revenue performance in a little bit more detail. Worldwide insurance exchange revenues grew 1% year-over-year. U.S. revenues grew 1% year-over-year. Our RCS revenues grew 21% year-over-year. I already talked about the EbixCash revenues growing 56% excluding the prepaid gift card revenue streams. Also, what was encouraging about Q2 โ22 results was the fact that our revenues grew year-over-year in 9 of the 10 geographies on a constant currency basis. On a GAAP basis, our revenues grew year-over-year in 8 of the 10 geographies of our business, despite the adverse effect of the U.S. dollar strengthening strongly after the Ukraine crisis. U.S. revenues had a year-over-year increase of 1%. Canada had a year-over-year increase of 7%. Brazil had a year-over-year increase of 62%. Singapore had a year-over-year increase of 11%. New Zealand had a year-over-year increase of 1%. Indonesia had a year-over-year increase of 450%. Philippines had a year-over-year increase 113%, while United Arab Emirates grew by a large percentage number also. Europe Q2 '22 GAAP revenues decreased by 4% year-over-year on account of strengthening of the U.S. dollar, while on a constant currency basis, European revenues increased 7% year-over-year in Q2 of '22. Australian Q2 '22 GAAP revenues decreased 9% year-over-year, primarily on account of the strengthening of the U.S. dollar, though on a constant currency basis, revenues were down 2% year-over-year. As Steve explained, Q2 '21 revenues in Australia were the highest revenues for a second quarter, since COVID-19 emerged globally. So, Australia had tough competition this quarter. Despite a 14% decline year-over-year in the gift card business, our EbixCash revenues on a GAAP and constant currency basis were higher than the Q2 '21 revenues. We are pleased with our India EbixCash results for second quarter of '22 as our most negatively impacted businesses from COVID-19 given EbixCash Limited experienced solid year-over-year growth in the second quarter of 2022. In total, our EbixCash business grew 56% year-over-year during the second quarter of '22, excluding the gift card business. Year-over-year growth in travel was 399% and year-over-year growth in foreign exchange revenues was 199%. Our e-learning business showed 596% growth year-over-year. Our remittance business grew 16% year-over-year during the second quarter of 2022. Our BPO business also grew 70% year-over-year. Sequentially, travel revenues grew 157%, foreign exchange grew 38%, remittance grew 47% and e-learning grew 102% in Q2 '22 as compared to Q1 '22. We are pleased with that trend. Ash talked in detail about the North American operations and the stellar job the North American staff has done under his leadership. Our North American operations have shown growth year-over-year on a six-month year-to-date basis in 2022 as compared to the six-month year-to-date period in 2021, as also in Q2 2022 versus Q1 2021. I'm pleased with that trend, as also the strides the exchange businesses have made in the region. Our Latin American management recently negotiated a large price raise with insurance client, whose network accounts for almost 50% of our revenues in the region. That will give us a consistent increased revenue stream in coming quarters in the region. EbixCash businesses continue to perform well, as discussed earlier. Recently, EbixCash payment solutions group inked new agreements with two highly recognized corporate names in India. One of the agreements was with Aakash Educational Services, a BYJU's company to provide cash management and collection services using EbixCash digital payment services and nationwide franchisee network. With a pan India network of 230-plus training centers, including its franchises, at an annual student count of more than 235,000. Aakash is a leading player in India's test preparation industry. Aakash was recently acquired by BYJU's, India's largest education company. The other agreement that EbixCash inked was with Amazon India. With various aspects to the agreement that we will mutually disclose through a press release at the appropriate time, amongst other agreements, our Bus Exchange division has also inked two new agreements with state roadways corporations in the Eastern Region of India. We will disclose details of that separately after seeking approval from the two clients. The EbixCash travel division continued its post-COVID-19 momentum with 399% year-over-year growth and 157% sequential growth. What stood out for me in terms of travel statistics for the division is as follows
- Operator:
- [Operator Instructions] Our first question comes from Jeff Van Rhee with Craig-Hallum.
- Jeff Van Rhee:
- Thanks, guys. Congrats on the underpinnings here. Definitely looks like steady improvement. Obviously, the gift cards are muddying the waters here, and we don't have a lot of clarity as to exactly what that number was, but I think, you gave a ton of content. I want to take it back up to a high level, if I could, Robin. If you look at the revenue growth you think you can deliver in FY23 ex gift card, I mean, can you put some bounds around how you think about โ23 excluding gift cards for top line growth?
- Robin Raina:
- Look, as you know, I hate to talk about any guidance with respect to revenues. I feel that our numbers speak for themselves right now with respect to many -- all around growth in revenues, across all geographies, across all, almost all divisions that are detailed out. So, I just feel very uncomfortable talking about any future guidance with respect to revenues.
- Operator:
- [Operator Instructions] And we have a follow-up from Jeff Van Rhee with Craig-Hallum.
- Jeff Van Rhee:
- Yes. Just to finish the thought on the EbixCash, Robin, is there any way you can share, you gave a lot of color around FX and all the instruments that are in that business remittance, et cetera. When you think about that business getting back to pre-pandemic levels, ex the gift card, is there any thinking there as a group when you can just at least get back to the pre-pandemic levels?
- Robin Raina:
- Well, I think, we believe that in the next six months, we should be back to that -- to the pre-pandemic level and possibly beat that pre-pandemic level. We are presently seeing a fantastic amount of growth in the market. There, what has happened post-COVID is a lot of the smaller players have basically perished, and some of the larger players who I hate to name are struggling. And part of it is our -- we have been dominating the foreign exchange markets. We've continued to add newer corporate clients. We continue to increase our positioning with respect to the airport business. It -- we've added -- in recent times, we have secured new approvals from Reserve Bank of India for new cards, newer licenses for certain new products, which puts us in a very unique position with respect to some of the FX business. So, we feel that we are in an extremely strong position with respect to that market, with respect to the foreign exchange business. So, I would -- I believe that in six monthsโ time we should be meeting or beating those pre-COVID numbers.
- Jeff Van Rhee:
- Steve, on the balance sheet, I know that's been a focus and obviously plan a is IPO. And I know you're working on that. But talk to the credit facility and just what's at work there to the extent you can share?
- Steve Hamil:
- Yes. I'm going to -- I'll let Robin also add some color on this. But at the current time, we are in compliance with our financial covenants with the credit agreement, able to meet the obligations associated with that. We obviously have an impending maturity, which we are trying to navigate, strategically handling that in conjunction with not only IPO but potentially alternative sources of capital to monetize value within, for instance, the EbixCash business, but Robin can certainly add some color to that.
- Robin Raina:
- Yes. Thank you, Steve. Thanks. Look, Jeff, you know this is our number one priority and we're going to handle this. I mean, we have -- we are absolutely focused on ensuring that we are in absolute compliance with all the credit lines and the refinancing efforts. There is a big effort on I cannot share any details with you because it wouldn't be right, as you can imagine, for me to be discussing any details. But rest assured that this is our number one priority. We feel we have a number of parallel channels that we are working on and we feel that we are going to get there. And yes, I think I'll stop at that for now simply because anything more than that, I have to share details, which I absolutely am not comfortable sharing, with respect to what we -- what and how -- what we are doing. As you know, when we had -- the last time, we took our credit line, I said the same stuff until we announced what we did. And so, we are going to just wait patiently and do the right thing. And once we have something to announce, we are going to announce it.
- Steve Hamil:
- And, Jeff, let me just add something from a historical perspective. If you look at our leverage ratio as defined in our bank agreement, which is publicly available, weโve delevered as of 6/30/22 in the last year, almost half a turn. And so, the combination of those scheduled amortization payments as well as the TTM EBITDA now creeping up, as these businesses that were impacted by COVID are rebounding is a positive sign. And we believe that, over the next couple of quarters, you are going to see that TTM EBITDA number continue to increase as those businesses rebound.
- Jeff Van Rhee:
- That's helpful. Maybe one last for me. Obviously, the data point that we are most interested in seems like many of them you are kind of hamstrung here, in terms of being able to talk about. But assuming the DRHP, you are able to go active and get the deal done, based on everything that I've been able to gather that both the valuation and in particular the proceeds would be very, very material. When you look at those proceeds, I think you outlined in the Draft Red Herring some of the use of proceeds. But I think it might be useful to revisit, how you think about use of funds if and when you complete that IPO, beyond the obvious that was stated in the Red Herring?
- Robin Raina:
- Well, I think that we already said that we will utilize $350 million of IPO proceeds to pay back, EbixCash would pay back the U.S. through the CCD route, where there is a CCD which is open. And having said that, there are few other things that we expect to do with respect to repayments back to the U.S., once we put our IPO in place. So, we feel that the IPO would be a -- could be a material way of paying, reducing the paying Ebix, Inc. back from EbixCash and in turn paying back our lenders. Now, that's -- at the same time, that's not our only approach. We have a parallel approach in place that we want to pursue parallelly and we are absolutely focused on both these parallel streams. Having said that, we continue to be highly bullish about our IPO. As you can tell once and DRHP is filed, it is impossible for us to talk about the details of when and how would that happen, because Indian rules are very specific about it that until SEBI has approved it, we're not supposed to talk about it. And so, as and when SEBI approves that, hopefully soon, then we will immediately be announcing that to the market. And you would -- and at that point, the process would be that the bankers would run a shadow book, they will go out and do some kind of a pre-marketing, we will decide on a particular valuation. And at that point, basically we'll then talk about a specific date or when we would launch the IPO and so on. And so, this is obviously a material event for us having an IPO. But IPO is -- obviously this is not just another event for us. We want to do it right. And we're focused on doing it the right way. And our bankers are very focused on doing it the right way. And we do believe we have a pioneering, differentiated story in the market. As you know that there are very few players with the kind of profitability that we have in the Indian markets, whether it is the financial market, whether it's a fintech market, or it is the on-demand markets in India. So, we do believe -- we and our bankers believe that we have a fantastic story to tell. So, we'll just -- we'll for now, just -- I'll stop at that. And we'll share more details as -- once we have more flexibility to provide more details. And hopefully once we have the approval, then we'll be able to talk about -- more about the specific timing.
- Jeff Van Rhee:
- Yes. Okay. Well, congrats. I mean, obviously U.S. business, EbixCash, gift card everything ahead of where we had expected it, and then unfortunately, gift card and stuff sometimes muddies the water here, but from my thoughts, congrats on the solid, fundamental numbers. I appreciate it.
- Robin Raina:
- Thank, Jeff.
- Operator:
- [Operator Instructions] Our next question comes from the line [Technical Difficulty]
- Robert Maltbie:
- Hello. It's Robert Maltbie sitting in for Christopher Sakai. Congratulations, gentlemen, on a good quarter. Everything considered in the global headwinds and the dollar. I've got two questions regarding opportunities in insurance with potential acquisitions. You mentioned attractive pricing in a possible shakeout, I believe. I was just curious, what are some of the underlying I guess factors driving these opportunities? And what would be maybe a catalyst that is driving that? And the second question relates to the Indian market, not being avid follower of that market and economy. What are you feeling in terms of the ongoing recovery of that economy and market over the next 12 months? Thank you.
- Robin Raina:
- Thank you. I think I'll address the second question first. Robert, first of all, always a pleasure talking to you. It's been a long time since I've spoken to you. Hello. And I'll try to address the second question first, and then Ash, maybe you can talk about the first one. With respect to the Indian economy. Look, India is emerging as one of the largest economies in the world. Right now they're targeting a $5 trillion economy over the next few years. That's basically the goal. If you look at the Indian stock markets, per se, when the U.S. markets were down 24% year-over-year, Indian markets were down 8%. So, the comparative effects in India have been lesser with respect to, for example, what's happened on the NASDAQ or what has happened on the NYSE. The other trend that has happened in India is that Indian markets have got very invert. Earlier, there was a lot of dependence on foreign institutions, FIs. If you look at in recent time, if you look at the amount -- some of the issues that are coming out, you're going to see that the Indian institutions have stepped up in a very large way. A very large part of investments is coming from Indian institutions. That has something to do with Mr. Modi's vision of make in India for the world, as he called it, where Indian institutions have stepped up and started investing in Indian IPOs per se, where IPs is based around in India, and they see some international opportunities of growth. Having said that, the government and if you talk to most economists, they tend to be very bullish about the Indian economy, per se, in terms of where the economy is headed. I think that's primarily it. From a technology and from the startup market perspective, the business, the markets are starting to come back. It is -- the recovery has been actually pretty decent in recent times with respect to the Indian market, if you compare it to the world market. So, yes, I think most of the economists that you would talk to would tend to be highly bullish about the Indian economy overall. Having said that, Ash, do you want to try to address the first one, the first question?
- Ash Sawhney:
- Yes. Sure, Robin. So, Robert, thanks for the question. What we see happening really is a shakeout. And what I mean by that is, if you look at the last maybe two to three years, during the boom time, you know, there were many companies that came to market, and they were funded by these VCs and private equity groups. And really, we believe they had flawed business models where they continue to show heavy, heavy losses, with a promise of producing stellar growth in future years. And by the way, this is not just in the insurance sector, this is like across the board, every industry. And what we're starting to see is tightening of the expectations by the investors. And some of these companies that have no line of sight into running a profitable business in the future, I think will be hurting. And that really draws attention to the strong business model that we have here at Ebix. We're a steady ship. We focus on profitable businesses. And as we've done in the past, we sit on the sidelines, and when we see opportunities to acquire these businesses that are in a distressed state, then we move. So, I hope that answers your question. It's not just an insurance industry specific dynamic. I think across all industries, it is back to basics. Itโs back to fundamentally how you run your business. And many of these companies are actually not running their businesses effectively.
- Operator:
- And I'm not showing any further questions at this time. Would you like me to repeat the instructions again?
- Robin Raina:
- Kevin, if there are no other questions, we can close the call. Thanks everyone for participating in the call. I look forward to speaking to each one of you in the third quarter investor call. With that, Iโll close the call. Kevin?
- Operator:
- Ladies and gentlemen, this concludes the presentation. You may now disconnect. And have a wonderful day.
Other Ebix, Inc. earnings call transcripts:
- Q1 (2023) EBIX earnings call transcript
- Q4 (2022) EBIX earnings call transcript
- Q3 (2022) EBIX earnings call transcript
- Q1 (2022) EBIX earnings call transcript
- Q4 (2021) EBIX earnings call transcript
- Q3 (2021) EBIX earnings call transcript
- Q2 (2021) EBIX earnings call transcript
- Q1 (2021) EBIX earnings call transcript
- Q4 (2020) EBIX earnings call transcript
- Q2 (2020) EBIX earnings call transcript